Stock Analiz

Innovative Eyewear Inc LUCY

Ophthalmic Goods · IPO 2022 · data as of November 13, 2026

$0.81Market cap $7M
Open the interactive analysis →

Innovative Eyewear Inc (LUCY) is a healthcare company listed in the US with a market value of about $7M. In the twelve months to September 30, 2026 it had revenue of $4M and net income of -$8M, a net margin of -216.8%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -314%.

About Innovative Eyewear

Innovative Eyewear is listed in the US and classified in ophthalmic goods, IPO year 2022. Revenue went from $690670 in 2021 to $3M in 2025, growth of about 40.1% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 949% over three years (dilution for shareholders). It spends 27% of revenue on research and development.

Score: 1.6 / 5

Value0/5
Future growth4/5
Track record0/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.9
P/B1.0
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-104.3%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)62.6%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-533.8%
ROIC (5-yr avg.)-314.0%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 5 years

Fiscal yearTTM20252024202320222021
Revenue$4M$3M$2M$1M$659788$690670
Net income-$8M-$8M-$8M-$7M-$6M-$3M
Free cash flow—-$7M-$7M-$6M-$3M-$1M
EPS (diluted)$-1.18$-1.90$-5.19$-10.87$-14.92—
Net margin-216.8%-285.2%-474.6%-578.2%-861.2%-469.8%
ROIC—-74.0%-68.8%-97.4%-109.5%-1220.1%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Innovative Eyewear pay a dividend?

Not currently.

Is Innovative Eyewear a good stock to buy?

We do not give buy or sell advice. Innovative Eyewear scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.